The global Cardiopulmonary Bypass Equipment Market is estimated to be valued at US$ 120.01 Mn or in 2023 and is expected to exhibit a CAGR of 1.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cardiopulmonary bypass equipment are devices used during open heart surgeries to temporarily take over the function of the heart and lungs and reroute the patient's blood circulation. The devices oxygenate and pump the blood allowing the heart to be stopped while surgery is performed.
Market key trends:
Advancements in telemetry has been a key trend in the cardiopulmonary bypass equipment market. Telemetry enable remote monitoring of patients physiological parameters during bypass procedures. This allows early detection of changes and interventions during surgery reducing complication risks. Integrating telemetry with digital platforms further enables monitoring from any location, data analytics and automated alerts.
Here is the segment analysis and key takeaways for the given Cardiopulmonary Bypass Equipment market:
Segment Analysis
The cardiopulmonary bypass equipment market is segmented by product type into heart-lung machines, oxygenators, pumps, cannulae, monitoring and analyzing systems, and others. The heart-lung machines segment dominates the market as these machines are the core component of cardiopulmonary bypass procedures, pumping and oxygenating blood outside the body to allow surgeons to operate on the heart.
Key Takeaways
The Global Cardiopulmonary Bypass Equipment Market Size is expected to witness high growth, exhibiting CAGR of 1.7% over the forecast period, due to increasing cardiac disease burden worldwide. According to WHO, cardiovascular diseases (CVDs) account for over 17.9 Mn deaths globally each year. Growth in the aging population prone to such conditions will propel the demand for CPB devices.
Regional analysis - North America dominates the cardiopulmonary bypass equipment market currently, owing to the strong healthcare infrastructure and high patient awareness. However, Asia Pacific is projected to grow at the fastest pace during the forecast period with increasing medical tourism and investments by industry players in developing markets like China and India.
Key players operating in the cardiopulmonary bypass equipment market are Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica, and Tianjin Medical. These established brands focus on new product launches and geographical expansion strategies to strengthen their market position.